Prescribing for Australians living with dementia: Study protocol using the Delphi technique

BMJ Open

Volumn 5, Issue 8, 2015, Pages

  Page, Amy ^a   Potter, Kathleen ^a   Clifford, Rhonda ^a   McLachlan, Andrew ^b   Etherton Beer, Christopher ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIAN; CLINICAL PROTOCOL; CONSENSUS; DELPHI STUDY; DEMENTIA; DRUG USE; ETHICS; HUMAN; INFORMED CONSENT; LIKERT SCALE; MEDICAL INFORMATION; PRESCRIPTION; QUALITATIVE ANALYSIS; QUESTIONNAIRE; STUDY DESIGN; AUSTRALIA; EVIDENCE BASED PRACTICE; FEMALE; GERIATRICS; LITERATURE; MALE; METHODOLOGY; QUALITATIVE RESEARCH; STANDARDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRALIA; DELPHI TECHNIQUE; DEMENTIA; DRUG PRESCRIPTIONS; EVIDENCE-BASED PRACTICE; FEMALE; GERIATRICS; HUMANS; MALE; QUALITATIVE RESEARCH; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; SURVEYS AND QUESTIONNAIRES;

EID: 84941595551     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-008048     Document Type: Article

References (53)

1. Larson EB, Shadlen MF, Wang L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-9.
2. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001;344:1111-16.
3. Australian Institute of Health and Welfare (AIHW). Dementia in Australia Canberra, Australia: AIHW, 2012.
4. Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007;3:186-91.
5. Schubert CC, Boustani M, Callahan CM, et al. Comorbidity profile of dementia patients in primary care: are they sicker?. J Am Geriatr Soc 2006;54:104-9.
6. Kunik ME, Snow AL, Molinari VA, et al. Health care utilization in dementia patients with psychiatric comorbidity. Gerontologist 2003;43:86-91.
7. Duthie A, Chew D, Soiza RL. Non-psychiatric comorbidity associated with Alzheimer's disease. QJM 2011;104:913-20.
8. Drewes YM, den Elzen WP, Mooijaart SP, et al. The effect of cognitive impairment on the predictive value of multimorbidity for the increase in disability in the oldest old: the Leiden 85-plus study. Age Ageing 2011;40:352-7.
9. Formiga F, Fort I, Robles MJ, et al. Comorbidity and clinical features in elderly patients with dementia: differences according to dementia severity. J Nutr Health Aging 2009;13:423-7.
10. Hoffmann F, van den Bussche H, Wiese B, et al. Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia. BMC Psychiatry 2011;11:190.
11. Somers M, Rose E, Simmonds D, et al. Quality use of medicines in residential aged care. Aust Fam Physician 2010;39:413-16.
12. Giron MS, Wang HX, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001;49:277-83.
13. Welsh TJ, Gladman JR, Gordon AL. The treatment of hypertension in people with dementia: a systematic review of observational studies. BMC Geriatr 2014;14:19.
14. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56:163-84.
15. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007;21:217-30.
16. Hilmer SN. ADME-tox issues for the elderly. Expert Opin Drug Metab Toxicol 2008;4:1321-31.
17. Van Spall H G C, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007;297:1233-40.
18. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging 2009;30:337-52.
19. Lindblad CI, Hanlon JT, Gross CR, et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther 2006;28:1133-43.
20. McCormick WC, Kukull WA, Van Belle G, et al. Symptom patterns and comorbidity in the early stages of Alzheimer's disease. J Am Geriatr Soc 1994;42:517-21.
21. Chang-Quan H, Hui W, Chao-Min W, et al. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies. Int J Clin Pract 2011;65:1295-305.
22. Stewart WF, Kawas C, Corrada M, et al. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48:626-32.
23. Ott A, Stolk RP, Van Harskamp F, et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999;53:1937-42.
24. Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000;356:1627-31.
25. In t' Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-21.
26. Chen Y, Zhou K, Wang R, et al. Antidiabetic drug metformin (Glucophage (R)) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc Natl Acad Sci U S A 2009;106:3907-12.
27. Holmes HM, Min LC, Yee M, et al. Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging 2013;30:655-66.
28. Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006;166:605-9.
29. van de Glind EM, van Enst WA, van Munster BC, et al. Pharmacological treatment of dementia: a scoping review of systematic reviews. Dement Geriatr Cogn Disord 2013;36:211-28.
30. Reisberg B, Borenstein J, Salob SP, et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987;48(Suppl):9-15.
31. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the cache county study on memory in aging. Am J Psychiatry 2000;157:708-14.
32. Bergh S, Selbæk G, Engedal K. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. BMJ 2012;344:e1566.
33. Seitz DP, Gill SS, Herrmann N, et al. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. Int Psychogeriatr 2013;25:185-203.
34. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMAn 2005;294:1934-43.
35. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007;63:725-31.
36. Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010;107:543-51.
37. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008;37:673-9.
38. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly an update. Arch Intern Med 1997;157:1531-6.
39. Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment)-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007;36:632-8.
40. Hsu CC, Sandford BA. The Delphi technique: making sense of consensus. Pract Assess Res Eval 2007;12:1-8.
41. McKenna HP. The Delphi technique: a worthwhile research approach for nursing? J Adv Nurs 1994;19:1221-5.
42. Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: Application of bootstrap data expansion. BMC Med Res Methodol 2005;5:37.
43. Campbell SM, Cantrill JA, Roberts D. Prescribing Indicators For UK General Practice: Delphi consultation study. BMJ 2000;321:425-8.
44. Rognstad S, Brekke M, Fetveit A, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. Scand J Prim Health Care 2009;27:153-9.
45. Powell C. The Delphi technique: Myths and realities. J Adv Nurs 2003;41:376-82.
46. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000;32:1008-15.
47. Keeney S, Hasson F, McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs 2006;53:205-12.
48. Rowe G, Wright G. The Delphi technique: Past, present, and future prospects-Introduction to the special issue. Technol Forecast Soc Change 2011;78:1487-90.
49. Qualtrics: Online Survey Software & Insight Platform [program]. 61093 version. Provo, Utah, USA, 2015.
50. NVivo qualitative data analysis software [program]. 10 version, 2012.
51. IBM SPSS Statistics for Windows, Version 22.0. [program]. Armonk, NY: IBM Corp., 2013.
52. Atkins D, Best D, Briss PA, et al., GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2013;328:1490-8.
53. GRADEpro Guideline Development Tool (G2DT) [program]. 2.xx version, 2014.